Current Cardiology Reports

, 21:137 | Cite as

Cardiovascular Consequences of Obstructive Sleep Apnea

  • Brynn K. DredlaEmail author
  • Pablo R. Castillo
Stroke (JF Meschia, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Stroke


Purpose of Review

To review the clinical evidence for a relationship between obstructive sleep apnea and hypertension, arrhythmias, coronary artery disease, and congestive heart failure.

Recent Findings

Current data show that obstructive sleep apnea is a risk for cardiovascular disease. Studies have linked untreated moderate to severe obstructive sleep apnea to hypertension, cardiac arrhythmias, coronary artery disease, and congestive heart failure. However, uncertainty regarding benefits of treatment of obstructive sleep apnea to reduce the risk of cardiovascular disease still exists. The issue of poor compliance has been an on-going limitation of CPAP trials.


Evidence shows obstructive sleep apnea is a risk factor for cardiovascular disease but trials have yet to clarify if cardiovascular disease morbidity and mortality decreases with treatment of the apnea. Future treatment trials are needed to address the question of whether treatment decreases cardiovascular risk in patients with obstructive sleep apnea.


Sleep apnea Cardiovascular disease Hypertension Obstructive sleep Apnea Arrhythmia Congestive heart failure 


Compliance with Ethical Standards

Conflict of Interest

Brynn K. Dredla and Pablo R. Castillo declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med [Internet]. 1993 Apr 29 [cited 2019 May 28];328(17):1230–5. Available from:
  2. 2.
    Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol [Internet]. 2013 May 1 [cited 2019 May 28];177(9):1006–14. Available from: CrossRefGoogle Scholar
  3. 3.
    Bixler EO, Vgontzas AN, Lin H-M, Ten Have T, Rein J, Vela-Bueno A, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med [Internet].2001 Mar 14 [cited 2019 Jun 1];163(3):608–13. Available from: CrossRefGoogle Scholar
  4. 4.
    Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, et al. AASM scoring manual updates for 2017 (version 2.4). J Clin Sleep Med. 2017;Google Scholar
  5. 5.
    Sateia MJ. International classification of sleep disorders-third edition. Chest. 2014;146:1387–94.CrossRefGoogle Scholar
  6. 6.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2016 update. Circulation [Internet]. 2016 Jan 26 [cited 2019 Jun 1];133(4). Available from:
  7. 7.
    Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol [Internet]. 2017 Feb 21 [cited 2019 May 26];69(7):841–58. Available from: CrossRefGoogle Scholar
  8. 8.
    Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev [Internet]. 2010 Jan [cited 2019 Jun 6];90(1):47–112. Available from: CrossRefGoogle Scholar
  9. 9.
    Mims KN, Kirsch D. 093 Sleep and stroke. Sleep Med Clin 2016, 11, 39, 51.CrossRefGoogle Scholar
  10. 10.
    Matsuura Y, Yamashita A, Iwakiri T, Sugita C, Okuyama N, Kitamura K, et al. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity. Thromb Haemost [Internet]. 2015 Nov 22 [cited 2019 Jun 22];114(07):158–72. Available from: CrossRefGoogle Scholar
  11. 11.
    Barceló A, Piérola J, de la Peña M, Frontera G, Yañez A, Alonso-Fernández A, et al. Impaired circadian variation of platelet activity in patients with sleep apnea. Sleep Breath [Internet]. 2012 Jun 6 [cited 2019 Jun 22];16(2):355–60. Available from: CrossRefGoogle Scholar
  12. 12.
    Song Y-J, Kwon JH, Kim JY, Kim BY, Cho KI. The platelet-to-lymphocyte ratio reflects the severity of obstructive sleep apnea syndrome and concurrent hypertension. Clin Hypertens [Internet]. 2015 Dec 4 [cited 2019 Jun 22];22(1):1. Available from:
  13. 13.
    Maruyama K, Morishita E, Sekiya A, Omote M, Kadono T, Asakura H, et al. Plasma levels of platelet-derived microparticles in patients with obstructive sleep apnea syndrome. J Atheroscler Thromb [Internet]. 2012 [cited 2019 Jun 22];19(1):98–104. Available from: CrossRefGoogle Scholar
  14. 14.
    Oga T, Chin K, Tabuchi A, Kawato M, Morimoto T, Takahashi K, et al. Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability. J Atheroscler Thromb [Internet]. 2010 [cited 2019 Jun 22];16(6):862–9. Available from: CrossRefGoogle Scholar
  15. 15.
    Marrone O, Salvaggio A, Bue A Lo, Bonanno A, Riccobono L, Insalaco G, et al. Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity. Clin Exp Hypertens [Internet]. 2011 Oct 2 [cited 2019 Jun 22];33(6):373–80. Available from: CrossRefGoogle Scholar
  16. 16.
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2002.Google Scholar
  17. 17.
    Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA [Internet]. 2012 May 23 [cited 2019 May 26];307(20):2169–76. Available from:
  18. 18.
    Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea: a systematic review and meta-analysis. Chest [Internet]. 2014 Apr 1 [cited 2019 Jun 9];145(4):762–71. Available from: CrossRefGoogle Scholar
  19. 19.
    Liu L, Cao Q, Guo Z, Dai Q. Continuous positive airway pressure in patients with obstructive sleep apnea and resistant hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens [Internet]. 2016 Feb 1 [cited 2019 Jun 9];18(2):153–8. Available from: CrossRefGoogle Scholar
  20. 20.
    Sapiña-Beltrán E, Torres G, Benítez I, Santamaría-Martos F, Durán-Cantolla J, Egea C, et al. Differential blood pressure response to CPAP treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnea. Eur Respir J [Internet]. 2019 May 16 [cited 2019 Jun 10];1900098. Available from:
  21. 21.
    Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias: is there a relationship? Am Rev Respir Dis [Internet]. 1993 Sep 17 [cited 2019 Jun 9];148(3):618–21. Available from: CrossRefGoogle Scholar
  22. 22.
    Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation [Internet]. 1998 Jun 2 [cited 2019 Jun 9];97(21):2154–9. Available from: CrossRefGoogle Scholar
  23. 23.
    Chokesuwattanaskul R, Thongprayoon C, Sharma K, Congrete S, Tanawuttiwat T, Cheungpasitporn W. Associations of sleep quality with incident atrial fibrillation: a meta-analysis. Intern Med J [Internet]. 2018 Aug 1 [cited 2019 May 26];48(8):964–72. Available from: CrossRefGoogle Scholar
  24. 24.
    Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing. Am J Respir Crit Care Med [Internet]. 2006 Apr 15 [cited 2019 Jun 9];173(8):910–6. Available from: CrossRefGoogle Scholar
  25. 25.
    Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation [Internet]. 2004 Jul 27 [cited 2019 May 26];110(4):364–7. Available from: CrossRefGoogle Scholar
  26. 26.
    Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol [Internet]. 2007 Feb 6 [cited 2019 Jun 9];49(5):565–71. Available from: CrossRefGoogle Scholar
  27. 27.
    Namtvedt SK, Randby A, Einvik G, Hrubos-Strøm H, Somers VK, Røsjø H, et al. Cardiac arrhythmias in obstructive sleep apnea (from the Akershus Sleep Apnea Project). Am J Cardiol [Internet]. 2011 Oct 15 [cited 2019 May 26];108(8):1141–6. Available from: CrossRefGoogle Scholar
  28. 28.
    Monahan K, Storfer-Isser A, Mehra R, Shahar E, Mittleman M, Rottman J, et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol [Internet]. 2009 Nov 3 [cited 2019 May 26];54(19):1797–804. Available from: CrossRefGoogle Scholar
  29. 29.
    Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J [Internet]. 2015 May 1 [cited 2019 May 26];169(5):647–654.e2. Available from: CrossRefGoogle Scholar
  30. 30.
    Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Meta-Analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol [Internet]. 2011 Jul 1 [cited 2019 May 26];108(1):47–51. Available from: CrossRefGoogle Scholar
  31. 31.
    Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman K V., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation [Internet]. 2003 May 27 [cited 2019 Jun 22];107(20):2589–94. Available from: CrossRefGoogle Scholar
  32. 32.
    Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation [Internet]. 2005 Oct 25 [cited 2019 Jun 9];112(17):2660–7. Available from: CrossRefGoogle Scholar
  33. 33.
    Shpilsky D, Erqou S, Patel SR, Kip KE, Ajala O, Aiyer A, Strollo PJ, Reis SE, Olafiranye O Association of OSA with microvascular endothelial dysfunction and subclinical coronary artery disease in a community-based population. [cited 2019 May 26]; Available from:, 23, 331, 339.CrossRefGoogle Scholar
  34. 34.
    Rivera-Pérez SJ, Martinez D, Araujo GN, Goncalves SC, Lazzaretti LK, Wainstein R V., et al. Severity of obstructive sleep apnea and extension of coronary artery disease. Sleep Breath [Internet]. 2018;1–6. Available from: CrossRefGoogle Scholar
  35. 35.
    Lee C-H, Sethi R, Li R, Ho H-H, Hein T, Jim M-H, et al. Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention. Circulation [Internet]. 2016 May 24 [cited 2019 May 26];133(21):2008–17. Available from: CrossRefGoogle Scholar
  36. 36.
    Gunnarsson SI, Peppard PE, Korcarz CE, Barnet JH, Aeschlimann SE, Hagen EW, et al. Obstructive sleep apnea is associated with future subclinical carotid artery disease thirteen-year follow-up from the Wisconsin sleep cohort. Arterioscler Thromb Vasc Biol. 2014;34(10):2338–42.CrossRefGoogle Scholar
  37. 37.
    Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med [Internet]. 2016 Sep 1 [cited 2019 May 26];194(5):613–20. Available from: CrossRefGoogle Scholar
  38. 38.••
    McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med [Internet]. 2016 Sep 8 [cited 2019 May 26];375(10):919–31. Available from: This article found CPAP use did not statistically prevent cardiovascular events in obstructive sleep apnea. CrossRefGoogle Scholar
  39. 39.
    Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea. JAMA [Internet]. 2017 Jul 11 [cited 2019 May 26];318(2):156. Available from: CrossRefGoogle Scholar
  40. 40.•
    Khan SU, Duran CA, Rahman H, Lekkala M, Saleem MA, Kaluski E. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea Eur Heart J [Internet]. 2018 Jun 21 [cited 2019 May 26];39(24):2291–7. Available from: Findings of this meta-analysis showed a tendency in reduction of cardiovascular events in patients with obstructive sleep apnea using CPAP greater than 4 h per night.
  41. 41.
    Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, et al. Prevalence and predictors of sleep-disordered breathing in patients eith stable chronic heart failure: the SchlaHF Registry. JACC Hear Fail [Internet]. 2016 Feb 1 [cited 2019 Jun 1];4(2):116–25. Available from:
  42. 42.
    Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U, et al. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J [Internet]. 2016 Jun 1 [cited 2019 May 26];37(21):1695–703. Available from: CrossRefGoogle Scholar
  43. 43.
    Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, et al. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J [Internet]. 2019 Apr 7 [cited 2019 May 26];40(14):1149–57. Available from: CrossRefGoogle Scholar
  44. 44.
    Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest [Internet]. 1988 Dec 1 [cited 2019 Jun 22];94(6):1200–4. Available from:

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Mayo ClinicJacksonvilleUSA

Personalised recommendations